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Defining the role of mesenchymal stromal cells on the regulation of matrix metalloproteinases in skeletal muscle cells 
Introduction
Skeletal muscle has a remarkable ability to regenerate after traumatic injury or disease. This is due to the presence of peculiar stem cells, satellite cells, which lie quiescent under the basal lamina of the muscle fibre until activated in response to injury, when they leave their niche and proliferate before differentiating into myoblasts and fuse into new myofibres [1] . These cells are characterized by the expression of paired box protein (Pax)-7 and myogenic differentiation markers (including Myf5, MyoD, and myogenin) in many muscles [2] . However, the propensity of these cells to repair skeletal muscle is limited in case of extended disease (muscular dystrophies and diabetes), exercise-induced injury [3] or altered use (immobilization, denervation, aging) [4] [5] [6] [7] ; in these cases, the amount of extracellular matrix (ECM) may increase dramatically relative to muscle fibres, resulting in scarring of the tissue. Muscle fibrosis continues to represent a challenge for clinicians and researchers since it impairs the complete muscle recovery, restricts range of motion, and predisposes to re-injury. Along this line, much attention has been given in the recent years to factors and therapeutic strategies that can improve skeletal muscle healing and regeneration, while reducing scar tissue formation. Studies conducted by our group and others have shown that muscle regeneration can be aided by the administration of growth factors [8] [9] [10] [11] [12] and bioactive lipids, including sphingosine 1-phosphate [13] [14] [15] . However, these factors are short-lived and more effective methods are required. Emerging evidence suggests that muscle repair can also benefit from stem cell therapy. To this aim, a variety of cell populations have been used, among which bone-marrow-derived mesenchymal stromal cells (MSCs) appear to be attractive candidates for myo-regenerative purposes [16] [17] [18] [19] [20] [21] [22] . This because these cells posses some interesting peculiarities for cell therapy, including the relatively easy isolation and expansion in culture, stable phenotype and limited rejection [23] . It is becoming increasingly clear that the MSCs offer benefits beyond their cell replacement potential by providing growth factors and cytokines with multiple effects in the host tissue microenvironment, including neoangiogenesis, the modulation of the endogenous repair mechanisms and prevention of injured cells from the stress response and apoptosis [24] [25] [26] [27] . In this context, we have previously demonstrated that MSCs stimulate neonatal cardiomyocyte and skeletal myoblast proliferation [20, 28] ; these effects are mainly mediated by the secretion of a variety of growth factors and cytokines, including vascular endothelial growth factor (VEGF) [20] . We have also shown that MSC transplantation contributes to skin regeneration by recruiting the local epithelial progenitors to participate in the repair process in the wound [29] . Of interest, the contribution to muscle repair by MSCs and their trophic factors may also involve modulation of fibrosis. Most studies on this field have focused on the role played by MSCs and other stem cells in ameliorating ventricular compliance and improving the cardiac performance after myocardial infarction [19, 26, [30] [31] [32] [33] [34] [35] . However, the role played by these cells in reducing fibrosis in diseased or injured skeletal muscle is less known.
With this in mind, the present study was undertaken to further understand and expand the paracrine activity of MSCs on skeletal muscle repair/regeneration, focusing on the effects of MSCs and their conditioned medium on the expression and activity of matrix metalloproteinases (MMPs), by skeletal C2C12 myoblasts, satellite cells and skeletal fibroblasts derived from mouse skeletal muscle tissue. MMPs are a family of enzymes that selectively digest individual components of ECM; their function is tightly regulated through the action of specific tissue inhibitors of metalloproteinases (TIMPs) and is required for muscle healing, by reducing fibrosis and promoting myogenic cell migration through the ECM to the site of injury [36] [37] [38] [39] [40] [41] . We found that factors released by MSCs exert potent anti-fibrotic effects via their ability to regulate the balance of MMP-2 and MMP-9/TIMP-1 and-2 production by the assayed muscle cells and improve satellite cell migration and differentiation, thus providing new insights into the potential role of MSC-cell therapy in muscle regenerative medicine. The animals were housed with free access to food and water and maintained on a 12 h light/dark cycle at 22 1C room temperature (RT). All efforts were made to minimize the animal suffering and the number of animals sacrificed. Animals were killed by decapitation.
Material and methods

Ethics statement
Cell culture and treatments
Mouse bone marrow mesenchymal stromal cells (m-MSCs) were isolated from femura and tibiae of male C2F1 mice, following the Dobson's procedure [42] , expanded in vitro and characterized as reported previously [20] . In some experiments, these cells were cultured at 37 1C in a humidified atmosphere of 5% CO 2 , in C2C12 myoblast differentiation medium (myoblast DM) or in muscle satellite culture medium or in NIH3T3 cell or primary skeletal fibroblast culture medium for 24 h and the culture medium (MSC-derived conditioned medium, MSC-CM) was harvested and used for culturing C2C12 myoblasts, satellite cells, single muscle fibres, NIH3T3 or primary skeletal fibroblasts to assess MSC paracrine effects.
Transgenic bone marrow green fluorescent protein (GFP)-labeled MSCs (GFP-MSCs) were isolated from male GFP transgenic Lewis rats (RRRC, Missouri, USA), expanded and characterized as described previously [43] . GFP-MSCs were analyzed for green fluorescence intensity at different passages in culture as well as for the expression of particular cell surface molecules using flow cytometry procedures: CD45-CyChromeTM, CD11b-FITC (in order to quantify hemopoietic-monocytic contamination), CD90-PE, CD73-PE, CD44-PE (BD Pharmingen, San Diego, CA, USA).
Murine C2C12 skeletal myoblasts obtained from American Type Culture Collection (ATCC, Manassas, VA, USA), were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin (Sigma, Milan, Italy) at 37 1C in a humidified atmosphere of 5% CO 2 till reaching 80% confluence. Then, they were shifted in differentiation medium (myoblast DM), containing 2% horse serum (HS, Sigma) and cultured for 24 h (control). In some experiments the cells were co-cultured with m-MSCs or rat GFP-MSCs at a 2:1 ratio for 24 h in myoblast DM. In parallel, C2C12 myoblasts were cultured in a bottom chamber of a polycarbonate transwell system (Millipore, Billerica, MA, USA) with MSCs put in top chamber, or exposed to MSC-CM (conditioned medium by MSCs cultured in myoblast DM for 24 h) in order to assess the paracrine effects of MSCs.
Single muscle fibres and satellite cells were isolated from Extensor Digitorum Longus (EDL) muscles carefully removed from anesthetized (with 50 μg/g zolazepam Tiletamine) young adult male Swiss mice (25-30 g) essentially as described previously [14] . Briefly, EDL muscles, soon after isolation, were digested in 0.2% collagenase type-I in DMEM (Sigma) and then transferred to a Petri dish containing serumfree DMEM, in which single muscle fibres were isolated from the muscles, by means a gentle mechanical trituration with a Pasteur pipette. The intact, viable muscle fibres were collected and subsequently cultured individually in Matrigel (BD Biosciences, San Jose, CA, USA) treated 24-well plates, at 37 1C in a humidified atmosphere of 5% CO 2 , in satellite cell proliferation medium containing DMEM, 20% FBS, 10% HS, 0.5% chicken embryo extract (Sera Laboratories International Ltd, Horsted Keynes, UK) plus 1% penicillin/streptomycin (Sigma) for 48 h. In some experiments after 24 h of culture, the myofibres were shifted in MSC-CM (conditioned medium by MSCs cultured in satellite proliferation medium for 24 h) for further 24 h. In other experiments, after 48 h of culture, the myofibres were removed and the derived satellite cells were expanded in culture in proliferation medium (control). In some experiments the cells (P1) were treated with MSC-CM (conditioned medium by MSCs cultured in satellite culture medium for 24 h) for 24 h and 48 h (at this time point, the MSC-CM was changed after 24 h). Satellite cells were assayed for Pax-7 expression by confocal immunofluorescence analysis to testify high purity of the culture.
Primary murine skeletal fibroblasts were prepared from EDL skeletal muscles, after the single myofibres were isolated and cultured in satellite cell proliferation medium as described above. In particular the cells sprouting from the 48 h cultured single myofibres, were detached after reaching 70% of confluence, with 0.05% trypsin-0.03% ethylenediaminetetraacetic acid (EDTA; Sigma) for 5 min at 37 1C, washed with phosphate buffered saline (PBS), and then seeded in a culture plate with fresh medium. After 20 min the non-adherent cells were collected and plated for satellite cell culture preparation, while the adherent ones (P0) were washed and shifted in DMEM supplemented with 20% FBS and 1% penicillin/streptomycin (Sigma) to be expanded at 37 1C in a humidified atmosphere of 5% CO 2 . Aliquots of cells at P1 culture passage were seeded on glass coverslips and assayed for vimentin and von Willebrand immunophenotype by confocal microscopy to confirm their stromal nature and to test the degree of purity of the cell cultures, which usually was 92-98%. To promote fibroblast-myofibroblast transition the cells were cultured in low serum (2% FBS) culture medium. In some experiments the fibroblastic cells (P1) were co-cultured with rat GFP-MSCs at a 1:1 ratio for 24 h in fibroblast low serum culture medium or were exposed to MSC-CM (conditioned medium by MSCs cultured in skeletal fibroblast low serum culture medium for 24 h) for 24 h.
Murine NIH3T3 fibroblasts obtained from ATCC were routinely cultured in DMEM supplemented with 10% FBS, and 1% penicillin/ streptomycin (Sigma) at 37 1C in a humidified atmosphere of 5% CO 2 . To promote fibroblast-myofibroblast transition the cells were cultured in low serum (2% FBS) culture medium. In some experiments the cells were co-cultured with rat GFP-MSCs at a 1:1 ratio or treated with MSC-CM (conditioned medium by MSCs cultured in fibroblast low serum culture medium for 24 h) for 24 h in order to assess the paracrine effects of MSCs.
In parallel experiments C2C12 cells and primary murine skeletal fibroblasts were cultured in the presence of 5 and 10 μM of a potent inhibitor of MMP-2 and MMP-9, SB-3CT (Sigma), as previously reported [44] .
Confocal immunofluorescence
The different cell types grown on glass coverslips were fixed with 0.5% buffered paraformaldehyde (PFA) for 10 min at RT. After permeabilization with cold acetone for 3 min, the fixed cells were blocked with 0.5% bovine serum albumin (BSA; Sigma) and 3% glycerol in PBS for 20 min and then incubated with the following primary antibodies: rabbit polyclonal anti-Ki67 
Flow cytometry
Flow cytometry analysis was performed to immune-phenotypically characterize C2C12 cell and mouse MSC populations with the aim to distinguish the two cell populations, when co-cultured, on the basis of their cell surface antigen, essentially as described previously [20] . Briefly, mouse MSCs and C2C12 cells recovered from flask by trypsin-EDTA treatment, were re-suspended in flow cytometry buffer consisting of CellWASH (0.1% sodium azide in PBS; Becton Dickinson, San Jose, CA, USA) with 2% FBS and incubated with PE-conjugated monoclonal antibodies (BD Pharmingen) against the myoblastic cell marker CD34 [45] ; 7-aminoactinomycin AAD (7-AAD; BD Pharmingen) was added in order to exclude dead cells from the analysis. Flow cytometric acquisition was performed by collecting 10 4 events on a FACSCanto (Becton Dickinson) instrument and data were analyzed on DIVA software (Becton Dickinson).
Immunomagnetic cell separation
C2C12 myoblasts and mouse MSCs were separated after 24 h coculture using MACS micro beads technology (Miltenyi Biotec, Bologna, Italy) essentially as reported previously [20] . In particular, the co-cultured cells were recovered by trypsin-EDTA treatment resuspended in Buffer containing 0.5% BSA and 2 mM EDTA and incubated with CD34 PE-conjugated antibody (BD Pharmingen) following manufacturer's instructions. Cells were then incubated with anti-PE MicroBeads and separated on MS MACS column following manufacturer's instructions (Miltenyi Biotec). The CD34 positive (C2C12 cells) cell fraction was then re-analyzed by flow cytometry to assess cell viability and purity and processed for Western blotting analysis. C2C12 cells in single culture were subjected to the same treatments of those in co-culture and used as control (CD34 þ C2C12 single culture). 
Western blotting
Gelatinase assay
The MMP activity in myoblasts and fibroblastic cells was evaluated using EnzCheks Gelatinase/Collagenase Assay Kit (Molecular Probes) which provides a highly quenched, fluorescein-labeled gelatin (DQ TM gelatin). Upon proteolytic digestion, the green fluorescence of the gelatin, is revealed and can be used to measure enzymatic activity. In particular, the wells of a 96-well microplate reader were coated with 25 μg/ml of DQ TM gelatin following the manufacturer's instructions; C2C12 or fibroblastic cells in different experimental culture conditions or the sole MSC-CM were added to the coated wells and incubated at 37 1C in a humidified atmosphere of 5% CO 2 , for 24 h before reading the fluorescent intensity by using a multi-well scanning spectrophotometer (ELISA reader; Amersham, Pharmacia Biotech, Cambridge, UK) at a wavelength of 515 nm. In parallel experiments, C2C12 cells were seeded onto glass coverslips previously coated with fluorescein-conjugated DQ TM gelatin (25 μg/ml) cultured for 24 h in DM or MSC-CM and then observed under a confocal Leica TCS SP5 microscope (Leica Microsystems).
In vitro cell migration assay
Cell migration assay was performed according to methods previously described [46] , with minor modifications. Briefly, C2C12 cells (3 Â 10 5 ) were cultured on glass coverslips coated with type-I collagen (Sigma) until 70% confluent in a complete medium. Cells were then shifted in DM or in CM-MSC in the presence or absence of SB-3CT (10 μM, Sigma), and cultured for 24 h before an artificial wound was created in the monolayer using a sterile plastic pipette tip. A perpendicular mark was placed across each scratch on the external surface of the glass coverslips to allow quantitative analysis. Repopulation of the wounded area was observed under phase contrast microscopy at 0 and 24 h after scraping. The average distance migrated by the cells was evaluated as the difference of the cell front relative to the 0 h time point, using ImageJ software (http://rsbweb.nih.gov/ij). After the analysis of cell migrating, the cells were fixed in 0.5% PFA, stained with Alexa Fluor 488 labelled-phalloidin (1:40 for 20 min at RT; Molecular Probes) to reveal actin filaments and observed by confocal Leica microscopy.
Time-lapse videomicroscopy
Single muscle fibres and the derived satellite cells were analyzed for 24 h by time-lapse videomicroscopy (1 frame/5 min, exposure time 0.5 s) using an inverted phase-contrast (Nikon, Tokyo, Japan) equipped with a 10 Â objective and a cooled video camera .05 vs MMP-2. 
Myotubes formation
Myotubes were also observed and their number evaluated after 48 h satellite cell culture in proliferation medium (control) or in MSC-CM, in 10 random 691.200 μm 2 optical square fields (20 Â ocular) under an inverted phase contrast microscope Nikon Diaphot 300 (Nikon) in each cell preparation (at least 10). 
Statistical analysis
Results
MSCs up-regulate MMP expression and activity in cultured myoblastic cells
To investigate the interactions between MSCs and skeletal myoblasts, we first co-cultured C2C12 cells with MSCs isolated from bone marrow of green fluorescent protein (GFP) transgenic Lewis rats (GFP-MSCs) or C2F1 mice (m-MSCs) for 24 h. As shown in Fig. 1 , C2C12 cells cultured alone expressed relatively high levels of MMP-9 and much lower levels of MMP-2, in agreement with our previous observations [31] . The co-presence of GFP-MSCs or m-MSCs in the culture, beside stimulating myoblast proliferation (81.276% and 61.175% of the myoblast nuclei resulted Ki67 positive in the coculture and single culture, respectively; Student's Test, po0.05) enhanced MMP-9 and MMP-2 production and down-regulated the expression of their inhibitors TIMP-1 and -2, as judged by confocal immunofluorescence (Fig. 1A-C) and Western blotting analysis performed in C2C12 cells immunomagnetically separated from mMSCs using antibodies against specific myoblastic cell markers (CD34) (Fig. 1D and E) . In particular, both MMP-2 and MMP-9 had similar subcellular distribution in the myoblastic cells and appeared linearly organized along the cytoskeletal filaments (Fig. 1A and B) . Their inhibitors, TIMP-1 and TIMP-2, appeared evenly distributed within the cytoplasm (Fig. 1A and B) . To monitor MSC-mediated paracrine effects, C2C12 cells were co-cultured with either GFPMSCs or m-MSCs using a transwell system or treated with MSCconditioned medium (MSC-CM) for 24 h. It was found that the expression levels of both MMP-2 and MMP-9 were increased by approximately two-folds after C2C12 cells were exposed to factors secreted by MSCs ( Fig. 2A and B) . In contrast, the expression of TIMP-1 and -2 were reduced (approximately by three and two-folds, respectively) in C2C12 cells treated with MSC-CM (Fig. 2B) . With DQ TM gelatin degradation assay, we also demonstrated that gelatinase (MMP-2 and MMP-9) activities of C2C12 cells were increased after exposure to MSC-CM ( Fig. 2C and D) , indicating that these cells synthesized functional MMPs. These data correlated with the increased cell motility observed in MSC-CM-treated cells as compared with control cells. In fact, utilizing a scrape migration assay, we found that the addition of MSC-CM significantly increased myoblast migration distance (Fig. 3A-D,G) . Interestingly, the incubation of the cells with SB-3CT, a potent MMP-2/9 inhibitor (Fig. 2C) , inhibited the effects of the MSC-CM on cell motility, reducing the migration distance into the artificial wound (Fig. 3A-D,G) . It is well known that a finely tuned balance between actin filament polymerization/depolymerization is required for cell migration [47] . Accordingly, MSC-CM treated cells, compared to the untreated controls, showed a more elongated shape along with a better organized cytoskeleton with robust stress fibers and expressed raft-like structures (i.e. microspikes and lamellipodia) at the migratory edge ( Fig. 3E and F) , suggestive of increased cell migration. By contrast, the cells incubated with SB-3CT (10 μM), revealed a round-shaped morphology and reduced cytoskeletal assembly ( Fig. 3E and F) . Altogether these data suggested that MSCs were able to regulate MMP expression and function in skeletal myoblasts through the release of paracrine factors. .05 vs C2C12þMSC-CM.
MSCs up-regulate MMP expression and promote myogenic differentiation in satellite cells
To further verify and extend the effects of MSCs on MMPs in myoblastic cells, we next evaluated whether MSC-CM influenced the expression of MMP-2 and MMP-9 in satellite cells isolated from single muscle fibres. By time-lapse videomicroscopy it was found that small mononucleated cells moved under the basal lamina of the muscle fibre and reached the surface of the host myofibre where they rapidly proliferated ( Fig. 4A and B ; Supplemental files 1,2). These cells expressed Pax-7 (Fig. 5) , which is considered a cell marker of satellite cells that are highly myogenic and self-renewable [2] . After the exposure to factors contained in the MSC-CM, MMP-2 and MMP-9 were up-regulated in Pax-7 þ satellite cells ( Fig. 5A and   B ), whereas the levels of TIMP-1 and TIMP-2 were down-regulated (Fig. 5B ). In these experimental conditions, these cells also showed .05 vs -SB-3CT.
increased motility, proliferation and differentiation potentials. This mostly on the basis of the following data showing that after the addition of MSC-CM: (i) a higher number of Pax-7 þ satellite cells sprouted from the single fibres (Fig. 6A) ; (ii) there was an increased fragmentation of the basal lamina around myofibres, as judged by laminin 2α immunostaining (Fig. 6A ), and; (iii) the sprouting myoblasts exhibited increased levels of MyoD, a marker of satellite cell activation [2] (Fig. 6A ) associated with a higher tendency to fuse into multinucleated myotubes (Fig. 6B ). These data taken together suggested that satellite cell migration and differentiation potentials could be promoted by MSC-CM, possibly by regulating MMP activity.
MSCs up-regulate MMP expression in skeletal fibroblasts and inhibit fibroblast-myofibroblast transition
Beside myoblasts, skeletal fibroblasts can also regulate ECM remodelling. Several lines of evidence suggest that this role is accomplished through two major mechanisms: secretion of ECMdegrading enzymes and differentiation into myofibroblasts, producing collagen and others ECM proteins [48] . On this background, we investigated whether skeletal fibroblasts could be a target of MSC-CM. Fibroblasts were isolated from mouse skeletal muscle and characterized at the first passage using morphological (flat and spindle-shaped with several projecting processes) and immunocytochemical (vimentin-positive and von Willebrand factor-negative) criteria (Fig. 7A) . In co-culture with GFP-MSCs, and after exposure to MSC-CM, skeletal fibroblasts and NIH3T3 fibroblastic cell line (data not shown) showed enhanced expression and activity of MMP-2 and MMP-9 ( Fig. 7B-E) , concomitant with reduced levels of TIMP-1 and TIMP-2 ( Fig. 7C and D) . This effect was associated with a decrease in α-smooth muscle actin (α-sma) ( Fig. 7B and C) , the most reliable marker of myofibroblasts, and type-I collagen expression in the cells cultured with GFP-MSCs or treated with MSC-CM ( Fig. 8A and B) , indicating that the anti-fibrotic potential of MSCs on skeletal muscle fibroblasts could be related not only to the stimulation of MMPs functions but also to the inhibition of their ability to undergo fibroblastmyofibroblast transition and accumulate collagen. Of interest, we also demonstrated that the pre-treatment with SB-3CT prevented the increase in MMP activity induced by MSC-CM (Fig. 7E ) and inhibited MSC-CM decreased α-sma and type-I collagen expression ( Fig. 8A and B) , suggesting that the preventive effects of paracrine factors from MSCs on fibroblast differentiation could be, at least in part, associated with MMP-pathway.
Discussion
The ECM provides the structural support of tissues and organs by serving as a scaffold for cells and determines their mechanical properties. Its homeostasis is dependent on a fine coordination between a family of proteolytic enzymes that selectively digest individual components of ECM, MMPs, and their specific tissue inhibitors (TIMPs). Over 25 members of the MMP family and 4 TIMPs family have been identified so far [41] . These molecules are constitutively expressed by a wide range of cell types from connective tissues, inflammatory and stem cells and are regulated by a number of growth factors, cytokines and chemokines. MMP/ TIMP balance plays pivotal roles in normal functioning tissues during growth, development and regeneration. Previous studies have, in fact, demonstrated that dismantling the ECM by MMP gelatinases, MMP-2 and MMP-9, is required for satellite cell activation and efficient skeletal muscle regeneration [1, 38, [49] [50] [51] [52] . Moreover, their inhibition negatively impact skeletal muscle healing [52] . MMP expression and function may also be associated with aberrant tissue repair response and disease progression in many tissues, including skeletal muscle [37, 53] . In particular, increased MMP-2 and MMP-9 activity has been found in severe muscular dystrophies, inflammatory myopathies, disuse atrophy, aging and injured muscle and is associated with the chronic persistence of inflammatory infiltrate, continuous cycles of myofibre degeneration and regeneration and massive proliferation of fibroblasts [5, 54] . In these conditions, the formation of a permanent fibrotic tissue surrounding the myofibres leads to a significant impairment of the muscle compliance and function and increases the susceptibility to re-injury. Of interest, the introduction of exogenous MMP-1 into the previously formed scar tissue of injured mouse gastrocnemius muscle results in a significant reduction of collagen content and improvement in the number of regenerating myofibres [55, 56] . These data suggest that increased MMP activity into the fibrotic tissue may be able to rescue the pathological muscle, making the tissue microenvironment more hospitable and conductive to cell regeneration. The mechanisms behind these effects are related to the fact that these enzymes disrupt ECM and the components of myofibre basement membrane that hinder myoblasts to reach the site of injury and differentiate and fuse into multinucleated fibers during muscle repair/regeneration. Along this line, we have shown in the present .05 vs MMP-2.
study that MSCs, which are emerging as good candidates for cellbased therapy to improve skeletal muscle repair/regeneration [17] [18] [19] , secrete paracrine factors capable of up-regulating MMPs in both skeletal muscle specific stem cells, myoblasts and satellite cells, and skeletal fibroblasts, thus providing clues for additional therapeutic options to counteract fibrosis in diseased skeletal muscle. Indeed, when compared to controls, C2C12 myoblasts and satellite cells co-cultured with MSCs or exposed to MSC-CM exhibited increased MMP-2 and MMP-9 expression and activity associated with a down-regulation of MMP inhibitors, TIMP-1 and TIMP-2. These data are consistent with our previous reports showing that C2C12 myoblasts and myofibre-associated satellite cells express MMP-2 and MMP-9 [14, 31] and that MSCs produce and release a wide variety of cytokines and growth factors, including interleukin (IL)-1, basal fibroblast growth factor (bFGF) and VEGF [20, 28] , which are considered highly potent inducers of MMP expression in many cell types [57] . In particular, it has been recently demonstrated that injection of VEGF into wounded skin increases neo-epidermal thickness and enhances re-epithelialization through the up-regulation of MMP-2 and MMP-9 expression [58] and preliminary data from our laboratory have indicated that the selective pharmacological VEGFR inhibition, using KRN633, markedly attenuates the expression of MMP-2 in C2C12 cells [personal communication] .
We also showed that MSC-CM promoted myoblast and satellite cell motility. In particular, using a scrape migratory assay, we demonstrated that MSC-CM-mediated myoblast motility was largely prevented by the incubation with a potent MMP inhibitor, SB-3CT. The inhibition of migration correlated with changes in cell morphology and in the cytoskeletal organization. Indeed, the typical actin motile structures, namely microspikes and ruffles/lamellipodia, observed at the migratory front were largely absent in the myoblasts pretreated with the MMP inhibitor prior the exposure to MSC-CM. In view of a previous study showing that MMP-2 physical interact with integrin and the actin cytoskeleton in glial cells [59] , it is possible to suggest that the increased MMP expression observed in myoblasts in response to paracrine factors from MSCs may influence myoblast cells migration not only through the increased pericellular proteolysis but also through the stimulation of functional interactions with the actin motile structures. This could also explain some of our data concerning the prevalent cytoskeletal distribution of MMP-2 and MMP-9 in the myoblastic C2C12 cells. On the other hand, the intracellular activity of MMPs is in line with the newly emerging evidence that these proteases, in particular MMP-2, beside their role as secreted proteins on ECM, can also rapidly act on several specific substrates inside the cells [60] . Moreover, the nuclear localization of MMPs in different cell types involves a novel biological action of these MMPs, consisting in a direct involvement in the regulation of gene transcription and expression [46, [60] [61] [62] .
Another interesting observation of the present study was the ability of MSC-CM to negatively interfere with myofibroblast differentiation of skeletal fibroblasts in primary cultures. Since myofibroblasts are believed to be the major contributors to tissue scarring, such findings provide further evidence for an anti-fibrotic effect of the conditioned media harvested from MSCs. Indeed, we have found that MSC-CM markedly attenuated the tendency of skeletal fibroblast to produce α-sma and type-I collagen. These data are consistent with those conducted in another study where vascular smooth muscle cells transplanted into the infarcted rat heart decreased myofibroblast activation and the subsequent maladaptive structural remodeling through paracrine mechanisms [63] . Interestingly, the inhibition of fibroblast-myofibroblast transition observed after the exposure to MSC-CM was significantly impaired when the cells were pre-treated with SB-3CT, suggesting the intriguing hypothesis that the cultured medium could suppress this phenomenon through putative MMP-dependent mechanisms. In support of this hypothesis, there are recent data that suppression of MMP-2 with TIMP-1 blocks hepatocyte growth factor (HGF)-decrease, α-sma and type-III collagen expression in transforming growth factor (TGF)-β-treated Achilles tendon fibroblasts [64] . The mechanisms whereby MMPs negatively influence myofibroblast activation and fibrosis are completely unknown. Efforts will continue in our laboratory to address this point and, in particular, to reveal any potential involvement of MMPs in the synthesis and secretion of profibrotic factors, such as TGF-β by the skeletal fibroblasts.
On the basis of the results of the present study it would be reasonable to hypothesize that the beneficial effects of MSC therapy for skeletal muscle repair/regeneration may also involve the ability of the engrafted cells to stimulate ECM remodeling and myoblast migration, as well as to attenuate myofibroblast formation and the subsequent excessive collagen production. In so doing, the engrafted cells and their released factors modify the local microenvironment and disrupt the mechanical barriers against the recruitment of the endogenous stem cells at the sites of muscle injury.To the best of our knowledge, this is the first experimental study to report the potential of MSC-derived paracrine factors to assist muscle remodelling through the upregulation of MMPs in different cell types.
We believe that the unique value of MSC therapy over the administration into the damaged muscle of single molecules, such E X P E R I M E N T A L C E L L R E S E A R C H 3 2 3 ( 2 0 1 4 ) 2 9 7 -3 1 3 as MMPs and/or their inhibitors or anti-fibrotic factors, which suffer of rapid clearance and relatively short half-life [7] , may reside in the possibility of the engrafted cells to release constant levels of paracrine signals that can act synergistically to stimulate the release of MMPs in the contest of the regenerating tissue to achieve more sustained therapeutic effects.
In conclusion, our data contribute to extend the therapeutic potential of MSCs for the treatment of diseased or injured skeletal muscle and open new prospective for understanding the mechanisms of action of MSCs in muscle healing. Our findings provide circumstantial evidence that these cells exert potent anti-fibrotic effects at least in part through the regulation of MMP/TIMP expression on different muscle cells and can be exploited to augment the beneficial effects of cell transplantation and improve and sustain their engraftment into the damaged muscle.
